Cargando…

A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens

A first or dominant immunization with one antigen markedly inhibited specific cytolytic T lymphocyte (CTL) responses to a second unrelated alloantigen without suppressing antibody responses to other antigens. Suppression was induced rapidly, became systemic, and could be transferred passively with o...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1993
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191159/
https://www.ncbi.nlm.nih.gov/pubmed/8350057
_version_ 1782146939300610048
collection PubMed
description A first or dominant immunization with one antigen markedly inhibited specific cytolytic T lymphocyte (CTL) responses to a second unrelated alloantigen without suppressing antibody responses to other antigens. Suppression was induced rapidly, became systemic, and could be transferred passively with only serum. Suppression did not result from elimination of cells capable of responding to the second antigen. The mechanisms responsible for this "priority of the first response" may be the same that help protect the fetus during pregnancy, promote renal allograft survival after multiple blood transfusions, and prevent effective CTL-mediated immunity to variants of tumor cells or infectious agents that arise during tumor progression or chronic infections.
format Text
id pubmed-2191159
institution National Center for Biotechnology Information
language English
publishDate 1993
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21911592008-04-16 A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens J Exp Med Articles A first or dominant immunization with one antigen markedly inhibited specific cytolytic T lymphocyte (CTL) responses to a second unrelated alloantigen without suppressing antibody responses to other antigens. Suppression was induced rapidly, became systemic, and could be transferred passively with only serum. Suppression did not result from elimination of cells capable of responding to the second antigen. The mechanisms responsible for this "priority of the first response" may be the same that help protect the fetus during pregnancy, promote renal allograft survival after multiple blood transfusions, and prevent effective CTL-mediated immunity to variants of tumor cells or infectious agents that arise during tumor progression or chronic infections. The Rockefeller University Press 1993-09-01 /pmc/articles/PMC2191159/ /pubmed/8350057 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens
title A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens
title_full A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens
title_fullStr A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens
title_full_unstemmed A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens
title_short A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens
title_sort first or dominant immunization. i. suppression of simultaneous cytolytic t cell responses to unrelated alloantigens
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191159/
https://www.ncbi.nlm.nih.gov/pubmed/8350057